Medical Marijuana, Inc. CEO and Subsidiary Kannaway® CEO Invited to Speak at SUCCESS Partners® CBD Symposium in Anaheim, California

SAN DIEGO, Jan. 23, 2019 — Medical Marijuana, Inc. (OTC:MJNA), the first-ever publicly traded cannabis company in the United States, announced today that Medical Marijuana, Inc. CEO Dr. Stuart Titus and Kannaway® CEO Blake Schroeder have been invited to speak at the CBD Symposium, hosted by SUCCESS Partners® in Anaheim, California.

The CBD Symposium is an invite-only event that will focus on direct selling market opportunities, as well as the many recent groundbreaking scientific advances, of cannabis and cannabidiol (CBD). In addition to addressing current legislative changes, hurdles and roadblocks for CBD in the U.S., speakers at the event, including Dr. Titus, will present on industry trends in product development and manufacturing.

“We are honored to be invited back to speak by this respected organization to discuss the benefits and challenges of entering the CBD market,” said Dr. Titus. “The event is a great opportunity for the company to network with other leaders in the CBD industry and showcase the many exciting projects and developments that our portfolio of companies is currently spearheading.”

SUCCESS Partners® empowers companies to achieve their full potential by providing strategic and creative solutions for growth, focusing on creating results through partnership, expertise and innovation. This is their second CBD Symposium and the company intends to use relevant insights and information from the previous event’s survey responses to help entrepreneurs and corporations with their future business initiatives.

“With the recent passage of the 2018 Farm Bill, we can only expect the U.S. hemp market to continue to grow, especially through direct selling enterprises,” Titus said.

About Medical Marijuana, Inc.

We are a company of firsts®. Our mission is to be the premier cannabis and hemp industry innovators, leveraging our team of professionals to source, evaluate and purchase value-added companies and products, while allowing them to keep their integrity and entrepreneurial spirit. We strive to create awareness within our industry, develop environmentally friendly, economically sustainable businesses, while increasing shareholder value. For details on Medical Marijuana, Inc.’s portfolio and investment companies, visit

To see Medical Marijuana, Inc.’s corporate video, click here.

Shareholders and consumers are also encouraged to buy CBD oil and other products at Medical Marijuana, Inc.’s shop.


This press release may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward-looking statements by definition involve risks, uncertainties and other factors, which may cause the actual results, performance or achievements of Medical Marijuana, Inc. to be materially different from the statements made herein.


These statements have not been evaluated by the FDA and are not intended to diagnose, treat or cure any disease.


Medical Marijuana, Inc. does not sell or distribute any products that are in violation of the United States Controlled Substances Act (US.CSA). These companies do grow, sell, and distribute hemp-based products and are involved with the federally legal distribution of medical marijuana-based products within certain international markets. Cannabidiol is a natural constituent of hemp oil.


Public Relations Contact:

Andrew Hard

Chief Executive Officer

CMW Media

P. 858-264-6600

[email protected]